Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Grant Grady III Insider Profile
4 Followers
Grant Grady III , Director at Aptevo Therapeutics, holds 198.00 shares in Aptevo Therapeutics (Ticker: APVO).
Grant Grady III has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Grant Grady III 's holdings
Insider Roles
Director
Roles that Grant Grady III holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:May 21, 2019 - May 21, 2020
Return:-41.90%
The most profitable trade made by Grant Grady III
Grant Grady III 's Trading History
List of latest transactions for each holding click on a transaction to see Grant Grady III 's performance on stock
You May Also Like
Grant Grady III insider profile FAQ
What is the percentage of profitable transactions made by Grant Grady III ?
The percentage of profitable transactions made by Grant Grady III is ―.
What is the average return per transaction made by Grant Grady III ?
The average return per transaction made by Grant Grady III is ―.
What stocks does Grant Grady III hold?
Grant Grady III holds: APVO stocks.
What was Grant Grady III ’s latest transaction?
Grant Grady III latest transaction was an Uninformative Buy of $62.65.
What was Grant Grady III 's most profitable transaction?
Grant Grady III ’s most profitable transaction was an Informative Buy of APVO stock on May 21, 2019. The return on the trade was -41.90%.
What is Grant Grady III 's role in Aptevo Therapeutics?
Grant Grady III 's role in Aptevo Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.